Botulin-A Toxin Instillations and Overactive Bladder
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this pilot study is to evaluate the safety and efficacy of direct
instillations of Botulinum-A toxin/DMSO into the bladder via a catheter system as a means of
treating women with symptoms of overactive bladder and secondary urinary incontinence. In
doing so, we will focus on estimating the percentage of women who experience an improvement
in their urinary incontinence symptoms at one month and three months following this novel
instillation technique.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A Dimethyl Sulfoxide incobotulinumtoxinA onabotulinumtoxinA Pharmaceutical Solutions